ICRA Nepal Allocate BBB- to Time Pharma, Upgrades Bikash Hydropower

ICRA Nepal has allocated a [ICRANP-IR] BBB- issuer rating to Time Pharmaceuticals Limited, placing it under intensive scrutiny with detrimental effects. This rating denotes a moderate degree of financial stability while also indicating a medium level of credit risk.

In contrast, ICRA Nepal has elevated the issuer rating of Bikash Hydropower Company Limited from [ICRANP-IR] BB to [ICRANP-IR] BBB-. The alterations in the rating reflect overall credit standing rather than pertaining to any particular debt instrument.